» Articles » PMID: 37635797

Prognostic Role of Euthyroid Sick Syndrome in MIS-C: Results from a Single-center Observational Study

Overview
Journal Front Pediatr
Specialty Pediatrics
Date 2023 Aug 28
PMID 37635797
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Euthyroid sick syndrome (ESS) is characterized by low serum levels of free triiodothyronine (fT3) with normal or low levels of thyroid stimulating hormone (TSH) and free thyroxine (fT4) and is reported in different acute clinical situations, such as sepsis, diabetic ketoacidosis and after cardiac surgery. Our aim was to evaluate the predicting role of ESS for disease severity in patients with Multisystem Inflammatory Syndrome in children (MIS-C).

Methods: A single-centre observational study on consecutive patients with MIS-C. Before treatment clinical, and laboratory data were collected and, in a subset of patients, thyroid function tests were repeated 4 weeks later. Variables distribution was analyzed by Mann-Whitney -test and correlations between different parameters were calculated by Spearman's Rho coefficient.

Results: Forty-two patients were included and 36 (85.7%) presented ESS. fT3 values were significantly lower in patients requiring intensive care, a strong direct correlation was shown between fT3 and Hb, platelet count and ejection fraction values. A significant inverse correlation was retrieved between fT3 levels and C-reactive protein, brain natriuretic peptide, IL-2 soluble receptor and S-100 protein. Subjects with severe myocardial depression (EF < 45%) had lower fT3 values than subjects with higher EF. The thyroid function tests spontaneously normalized in all subjects who repeated measurement 4 weeks after admission.

Conclusion: ESS is a frequent and transient condition in acute phase of MIS-C. A severe reduction of fT3 must be considered as important prognostic factor for severe disease course, with subsequent relevant clinical impact in the management of these patients.

References
1.
Calcaterra V, Biganzoli G, Dilillo D, Mannarino S, Fiori L, Pelizzo G . Non-thyroidal illness syndrome and SARS-CoV-2-associated multisystem inflammatory syndrome in children. J Endocrinol Invest. 2021; 45(1):199-208. PMC: 8312710. DOI: 10.1007/s40618-021-01647-9. View

2.
Peeters R, Wouters P, Kaptein E, van Toor H, Visser T, Van den Berghe G . Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients. J Clin Endocrinol Metab. 2003; 88(7):3202-11. DOI: 10.1210/jc.2002-022013. View

3.
Pingitore A, Landi P, Taddei M, Ripoli A, LAbbate A, Iervasi G . Triiodothyronine levels for risk stratification of patients with chronic heart failure. Am J Med. 2005; 118(2):132-6. DOI: 10.1016/j.amjmed.2004.07.052. View

4.
Lacina L, Brabek J, Fingerhutova S, Zeman J, Smetana Jr K . Pediatric Inflammatory Multisystem Syndrome (PIMS) - Potential role for cytokines such Is IL-6. Physiol Res. 2021; 70(2):153-159. PMC: 8820574. DOI: 10.33549/physiolres.934673. View

5.
Haslak F, Gunalp A, Kasapcopur O . A cursed goodbye kiss from severe acute respiratory syndrome-coronavirus-2 to its pediatric hosts: multisystem inflammatory syndrome in children. Curr Opin Rheumatol. 2022; 35(1):6-16. DOI: 10.1097/BOR.0000000000000910. View